CB1 agonist 1

• Description:

  CB1 agonist 1 (compound 22) is an agonist of CB1. CB1 agonist 1 shows affinity to CB1 receptor with an pIC50 value of 5.7. CB1 agonist 1 can be used for the research of brain disorders[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H302, H315, H319

• Target:

  Cannabinoid Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/cb1-agonist-1.html

• Purity:

  99.84

• Solubility:

  DMSO : 250 mg/mL (ultrasonic)

• Smiles:

  O=C (C1=C (OC2=CC=CC=C2) C=CC=C1) NC3=CC=C (C) C (S (=O) (N4CCOCC4) =O) =C3

• Molecular Formula:

  C24H24N2O5S

• Molecular Weight:

  452.52

• Precautions:

  H302, H315, H319

• References & Citations:

  [1]Lambeng N, et al. Arylsulfonamides as a new class of cannabinoid CB1 receptor ligands: identification of a lead and initial SAR studies. Bioorg Med Chem Lett. 2007 Jan 1;17 (1) :272-7.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C, 3 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  851212-80-1